查看購物車
  • Simplified Chinese
  • English
DNA 質粒製造市場規模及預測 2021 - 2031、全球及地區佔有率、趨勢及成長機會分析報告涵蓋範圍：按產品類型、應用、最終用戶和地理分類
市場調查報告書
商品編碼
1761175

DNA 質粒製造市場規模及預測 2021 - 2031、全球及地區佔有率、趨勢及成長機會分析報告涵蓋範圍：按產品類型、應用、最終用戶和地理分類

DNA Plasmid Manufacturing Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User and Geography
出版日期: | 出版商: The Insight Partners | 英文 222 Pages | 訂單完成後即時交付

價格

DNA質粒製造市場預計將從2024年的6.8638億美元增至2031年的26.4836億美元；預計2025-2031年期間的複合年成長率將達到21.4%。推動市場成長的主要因素包括基因治療質粒研發的不斷增加以及DNA質粒疫苗研發的持續深入。然而，高昂的製造成本是阻礙市場發展的因素之一。

遺傳疾病、孤兒疾病和其他癌症的發生率上升加速了基因治療技術的進步，而基因治療技術主要以質粒DNA為基本元件。質粒DNA有助於將遺傳物質引入患者細胞。它作為一種非病毒載體，遞送治療基因，從而修復或替換缺陷基因。與病毒載體不同，質粒更安全、更容易生產且成本更低，因此在基因治療中廣受歡迎。

隨著基因療法從臨床前開發階段過渡到臨床試驗和商業化上市，對大量高純度、GMP 級質粒 DNA 的需求顯著成長。 2023 年 3 月，Charles River Laboratories International, Inc. 宣布推出其現成的 pHelper（輔助質粒）產品，旨在確保供應，並簡化基於腺相關病毒 (AAV) 的基因治療項目從早期發現到商業化生產的整個流程。

不斷拓展公司間的合作關係，以滿足基因治療產品線的品質和監管需求。 2022年，Myrtelle 和 Forge Biologics 宣佈建立病毒載體和質粒 DNA cGMP 生產合作夥伴關係。 Forge 將為 Myrtelle 的 Myr-201 計畫（用於治療單基因聽力損失的新型基因療法）提供研究級和 GMP-Pathway 質粒生產服務，以及 cGMP 腺相關病毒 (AAV) 製程開發和規模化生產服務。

政府和監管機構也透過加快基因治療產品的核准和國家生物技術基礎設施投資來推動這一趨勢。 VGXI公司最近在其位於德克薩斯州康羅的GMP工廠成功通過了FDA檢查。此檢查促成了客戶生物製品許可證申請(BLA)的批准。 VGXI的成就鞏固了其作為質粒DNA製造領導者的信譽，並凸顯了其在商業化階段基因療法、DNA疫苗和RNA藥物方面的重要性。

DNA質粒市場正從一條專業研究供應鏈轉型為當代治療發展的重要支柱。因此，基因治療質粒的蓬勃發展推動了DNA質粒製造市場的發展。

比較公司分析基於產品組合（產品滿意度、產品特性和可用性）、近期市場發展（併購、新產品發布和改進、投資和融資、獎項、協議、合作與夥伴關係、認可和擴張）以及地理位置，對 DNA 質粒製造市場進行評估和分類，以幫助企業更好地做出決策並了解競爭格局。該報告深入探討了全球 DNA 質粒製造市場領先供應商近期的重大發展和創新。主要的市場參與者包括藥明生物製藥公司、Charles River Laboratories International Inc、康泰倫特公司、賽默飛世爾科技公司、AGC Biologics AS、寶生物株式會社、SK pharmteco Inc、賽多利斯公司、Creative Biogene 和金斯瑞生物科技公司。

根據產品類型，DNA 質粒製造市場分為 GMP 級和研發級。 GMP 級細分市場在 2024 年佔據 DNA 質粒製造市場的最大佔有率，預計在 2024-2031 年期間將實現最高複合年成長率。根據應用，DNA 質粒製造市場細分為細胞和基因治療、DNA 疫苗、免疫治療和其他。 2024 年，細胞和基因治療細分市場佔據最大的市場佔有率。根據最終用戶，DNA 質粒製造市場細分為製藥和生物技術公司、合約研究組織 (CRO) 和合約研發生產組織 (CDMO) 以及其他。 2024 年，製藥和生技公司細分市場佔據最大的市場。

DNA質粒製造市場的公司採用各種有機和無機成長策略。有機成長策略主要包括產品發布和產品批准。市場上常見的無機成長策略包括收購、合作和夥伴關係。這些成長策略使市場參與者能夠擴展業務，增強地域影響力，並促進整體市場成長。此外，收購和夥伴關係等策略有助於鞏固客戶群並擴展產品組合。以下列出了DNA質粒製造市場主要參與者的一些重要進展。

2025年3月，藥明生物推出EffiX微生物表現平台，協助重組蛋白及質粒DNA生產。 EffiX旨在滿足業界對高產量、穩定、非溶源性大腸桿菌表達系統的需求。該平台為全球客戶開發和生產非單株抗體（non-mAb）重組蛋白和質粒DNA提供全面的解決方案。 EffiX可在多種生產模式下達到高產量，非mAb重組蛋白的滴度超過15 g/L，質粒DNA的滴度超過1 g/L。

目錄

第1章：簡介

第2章：執行摘要

  • 分析師市場展望

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：
  • 假設和局限性

第4章：DNA質粒製造市場格局

  • PEST分析

第5章：DNA質粒製造市場－關鍵市場動態

  • DNA質粒製造市場－關鍵市場動態
  • 市場促進因素
    • 增加質粒的基因治療開發
    • DNA質粒疫苗研發研究日益活躍
  • 市場限制
    • 製造成本高
  • 市場機會
    • 合約開發和製造組織 (CDMO) 的擴張
  • 未來趨勢
    • 數位技術在質粒DNA製造中的整合
  • 促進因素和限制因素的影響：

第6章：DNA質粒製造市場-全球市場分析

  • DNA質粒製造市場收入（2021-2031）
  • DNA質粒製造市場預測分析

第7章：DNA質粒製造市場分析－依產品類型

  • GMP級
  • 研發級

第 8 章：DNA 質粒製造市場分析 - 按應用

  • 細胞和基因治療
  • DNA疫苗
  • 免疫療法
  • 其他

第9章：DNA質粒製造市場分析－依最終用戶

  • 製藥和生物技術公司
  • CRO 和 CDMO
  • 其他

第 10 章：DNA 質粒製造市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 2024年公司市佔率分析

第 12 章：產業格局

  • 概述
  • 奈及利亞傳染病體外診斷市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第13章：公司簡介

  • Sartorius AG
  • WuXi Biologics Inc
  • Charles River Laboratories International Inc
  • Catalent Inc
  • Thermo Fisher Scientific Inc.
  • AGC Biologics AS
  • Takara Bio Inc
  • Creative Biogene
  • SK Pharmteco Inc
  • GenScript Biotech Corporation

第 14 章：附錄

Product Code: TIPRE00021640

The DNA plasmid Manufacturing Market is expected to reach US$ 2,648.36 Mn by 2031 from US$ 686.38 Mn in 2024; the market is estimated to grow at a CAGR of 21.4% during 2025-2031. Major factors driving the market growth include increasing plasmid developments for gene therapy and growing research on DNA plasmid vaccine development. However, high manufacturing costs among the market deterrents.

The rise in the prevalence of genetic diseases, orphan diseases, and other cancers has accelerated the advancement of gene therapy technologies, which are based largely on plasmid DNA as the fundamental element. Plasmid DNA helps introduce genetic material into patients' cells. It acts as a non-viral vector to deliver therapeutic genes that can fix or replace faulty genes. Unlike viral vectors, plasmids are safer, easier to produce, and cheaper, making them popular in gene therapy.

As gene therapies transition from preclinical development to clinical trials and commercial launch, the demand for substantial quantities of high-purity, GMP-grade plasmid DNA has escalated significantly. In March 2023, Charles River Laboratories International, Inc. announced the launch of its off-the-shelf pHelper (Helper Plasmid) offering, which is designed to secure supply and streamline adeno-associated virus (AAV)-based gene therapy programs from early discovery through commercial manufacturing.

Growing partnerships between companies to meet the quality and regulatory demands of gene therapy pipelines. In 2022, Myrtelle and Forge Biologics announced a viral vector and plasmid DNA cGMP manufacturing partnership. Forge will provide research-grade and GMP-Pathway plasmid manufacturing services as well as cGMP adeno-associated viral (AAV) process development and scale-up manufacturing services for Myrtelle's program, Myr-201 (novel gene therapy for monogenic hearing loss).

Governments and regulatory agencies are also helping to drive this trend with expedited approvals for gene therapy products and national biotech infrastructure investment. VGXI, Inc. recently completed a successful FDA inspection at its GMP facility in Conroe, Texas. This inspection led to the approval of a client's Biologics License Application (BLA). VGXI's achievement reinforces its credibility as a plasmid DNA manufacturing leader as well as underscores its importance in enabling commercial-stage gene therapies, DNA vaccines, and RNA-based medicines.

The DNA plasmid market is transforming from a specialized research supply chain to an essential backbone of contemporary therapeutic development. Therefore, the increasing development of plasmid for gene therapy drives the DNA plasmid manufacturing market.

The comparative company analysis evaluates and categorizes the DNA plasmid Manufacturing Market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global DNA plasmid Manufacturing Market. The key market players are WuXi Biologics Inc, Charles River Laboratories International Inc, Catalent Inc, Thermo Fisher Scientific Inc., AGC Biologics AS, Takara Bio Inc, SK pharmteco Inc, Sartorius, Creative Biogene, GenScript Biotech Corporation

The DNA plasmid Manufacturing Market, based on product type, is divided into GMP Grade and R&D grade. The GMP Grade segment held the largest share of the DNA plasmid Manufacturing Market in 2024, and it is expected to register the highest CAGR during 2024-2031. Based on Application, the DNA plasmid Manufacturing Market is segmented into Cell and Gene Therapy, DNA Vaccines, Immunotherapy, and Others. In 2024, the cell and gene therapy segment held the largest share of the market. Based on end user, the DNA plasmid Manufacturing Market is segmented into Pharmaceutical and Biotechnology Companies, CROs and CDMOs and Others. In 2024, the Pharmaceutical and Biotechnology Companies segment held the largest share of the market.

Various organic and inorganic strategies are adopted by companies operating in the DNA plasmid Manufacturing Market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the DNA plasmid Manufacturing Market are listed below.

In March 2025, WuXi Biologics Launched EffiX Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA Production. EffiX is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for developing and manufacturing non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for clients across the globe. EffiX delivers high-yield production across multiple modalities, achieving titers of over 15 g/L for non-mAb recombinant proteins and over 1 g/L for plasmid DNA.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. DNA Plasmid Manufacturing Market Landscape

  • 4.1 PEST Analysis

5. DNA Plasmid Manufacturing Market - Key Market Dynamics

  • 5.1 DNA Plasmid Manufacturing Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Plasmid Developments for Gene Therapy
    • 5.2.2 Growing Research on DNA Plasmid Vaccine Development
  • 5.3 Market Restraints
    • 5.3.1 High Manufacturing Costs
  • 5.4 Market Opportunities
    • 5.4.1 Expansion of Contract Development and Manufacturing Organizations (CDMOs)
  • 5.5 Future Trends
    • 5.5.1 Integration of Digital Technologies in Plasmid DNA Manufacturing
  • 5.6 Impact of Drivers and Restraints:

6. DNA Plasmid Manufacturing Market - Global Market Analysis

  • 6.1 DNA Plasmid Manufacturing Market Revenue (US$ Million), 2021-2031
  • 6.2 DNA Plasmid Manufacturing Market Forecast Analysis

7. DNA Plasmid Manufacturing Market Analysis - by Product Type

  • 7.1 GMP Grade
    • 7.1.1 Overview
    • 7.1.2 GMP Grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 R&D grade
    • 7.2.1 Overview
    • 7.2.2 R&D grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

8. DNA Plasmid Manufacturing Market Analysis - by Application

  • 8.1 Cell and Gene Therapy
    • 8.1.1 Overview
    • 8.1.2 Cell and Gene Therapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 DNA Vaccines
    • 8.2.1 Overview
    • 8.2.2 DNA Vaccines: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Immunotherapy
    • 8.3.1 Overview
    • 8.3.2 Immunotherapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

9. DNA Plasmid Manufacturing Market Analysis - by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Overview
    • 9.1.2 Pharmaceutical and Biotechnology Companies: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 CROs and CDMOs
    • 9.2.1 Overview
    • 9.2.2 CROs and CDMOs: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

10. DNA Plasmid Manufacturing Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America DNA Plasmid Manufacturing Market Overview
    • 10.2.2 North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.2.3 North America: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.2.3.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.2.4 North America: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.2.4.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.2.5 North America: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.2.5.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.2.6 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.2 United States: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.2.1 United States: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.2.6.2.2 United States: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.2.6.2.3 United States: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.2.6.3 Canada: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.3.1 Canada: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.2.6.3.2 Canada: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.2.6.3.3 Canada: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.2.6.4 Mexico: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.4.1 Mexico: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.2.6.4.2 Mexico: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.2.6.4.3 Mexico: DNA Plasmid Manufacturing Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe DNA Plasmid Manufacturing Market Overview
    • 10.3.2 Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.3.3 Europe: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.3.3.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.3.4 Europe: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.3.4.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.3.5 Europe: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.5.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.3.6 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.2 Germany: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.2.1 Germany: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.2.2 Germany: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.2.3 Germany: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.3 United Kingdom: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.3.1 United Kingdom: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.3.2 United Kingdom: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.3.3 United Kingdom: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.4 France: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.4.1 France: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.4.2 France: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.4.3 France: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.5 Italy: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.5.1 Italy: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.5.2 Italy: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.5.3 Italy: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.6 Spain: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.6.1 Spain: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.6.2 Spain: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.6.3 Spain: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.7 Rest of Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.7.1 Rest of Europe: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.7.2 Rest of Europe: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.7.3 Rest of Europe: DNA Plasmid Manufacturing Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific DNA Plasmid Manufacturing Market Overview
    • 10.4.2 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.4.3 Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.4.3.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.4.4 Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.4.4.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.4.5 Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.5.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.4.6 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.2 China: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.2.1 China: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.2.2 China: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.2.3 China: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.3 Japan: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.3.1 Japan: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.3.2 Japan: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.3.3 Japan: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.4 India: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.4.1 India: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.4.2 India: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.4.3 India: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.5 Australia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.5.1 Australia: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.5.2 Australia: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.5.3 Australia: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.6 South Korea: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.6.1 South Korea: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.6.2 South Korea: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.6.3 South Korea: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.7 Rest of APAC: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.7.1 Rest of APAC: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.7.2 Rest of APAC: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.7.3 Rest of APAC: DNA Plasmid Manufacturing Market Breakdown, by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa DNA Plasmid Manufacturing Market Overview
    • 10.5.2 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.5.3 Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.5.3.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.5.4 Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.5.4.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.5.5 Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.5.5.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.5.6 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.2 Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.2.1 Saudi Arabia: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.5.6.2.2 Saudi Arabia: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.5.6.2.3 Saudi Arabia: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.5.6.3 South Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.3.1 South Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.5.6.3.2 South Africa: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.5.6.3.3 South Africa: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.5.6.4 United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.4.1 United Arab Emirates: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.5.6.4.2 United Arab Emirates: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.5.6.4.3 United Arab Emirates: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.5.6.5 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.5.1 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.5.6.5.2 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.5.6.5.3 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America DNA Plasmid Manufacturing Market Overview
    • 10.6.2 South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.6.3 South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.6.3.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.6.4 South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.6.4.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.6.5 South and Central America: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.6.5.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.6.6 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.2 Brazil: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.2.1 Brazil: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.6.6.2.2 Brazil: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.6.6.2.3 Brazil: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.6.6.3 Argentina: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.3.1 Argentina: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.6.6.3.2 Argentina: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.6.6.3.3 Argentina: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.6.6.4 Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.4.1 Rest of South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.6.6.4.2 Rest of South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.6.6.4.3 Rest of South and Central America: DNA Plasmid Manufacturing Market Breakdown, by End User

11. Competitive Landscape

  • 11.1 Heat Map Analysis by Key Players
  • 11.2 Company Market Share Analysis, 2024

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Sartorius AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 WuXi Biologics Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Charles River Laboratories International Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Catalent Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Thermo Fisher Scientific Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 AGC Biologics AS
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Takara Bio Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
  • 13.8 Creative Biogene
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 SK Pharmteco Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 GenScript Biotech Corporation
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. DNA Plasmid Manufacturing Market Segmentation
  • Table 2. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million)
  • Table 3. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million)
  • Table 4. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 5. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 6. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 7. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 8. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 9. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 10. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 11. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 12. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 13. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 14. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 15. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 16. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 17. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 18. United States: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 19. United States: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 20. United States: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 21. United States: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 22. United States: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 23. United States: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 24. Canada: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 25. Canada: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 26. Canada: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 27. Canada: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 28. Canada: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 29. Canada: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 30. Mexico: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 31. Mexico: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 32. Mexico: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 33. Mexico: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 34. Mexico: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 35. Mexico: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 36. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 37. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 38. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 39. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 40. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 41. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 42. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 43. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 44. Germany: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 45. Germany: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 46. Germany: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 47. Germany: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 48. Germany: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 49. Germany: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 50. United Kingdom: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 51. United Kingdom: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 52. United Kingdom: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 53. United Kingdom: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 54. United Kingdom: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 55. United Kingdom: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 56. France: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 57. France: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 58. France: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 59. France: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 60. France: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 61. France: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 62. Italy: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 63. Italy: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 64. Italy: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 65. Italy: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 66. Italy: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 67. Italy: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 68. Spain: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 69. Spain: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 70. Spain: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 71. Spain: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 72. Spain: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 73. Spain: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 74. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 75. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 76. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 77. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 78. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 79. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 80. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 81. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 82. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 83. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 84. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 85. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 86. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 87. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 88. China: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 89. China: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 90. China: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 91. China: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 92. China: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 93. China: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 94. Japan: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 95. Japan: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 96. Japan: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 97. Japan: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 98. Japan: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 99. Japan: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 100. India: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 101. India: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 102. India: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 103. India: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 104. India: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 105. India: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 106. Australia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 107. Australia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 108. Australia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 109. Australia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 110. Australia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 111. Australia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 112. South Korea: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 113. South Korea: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 114. South Korea: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 115. South Korea: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 116. South Korea: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 117. South Korea: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 118. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 119. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 120. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 121. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 122. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 123. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 124. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 125. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 126. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 127. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 128. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 129. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 130. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 131. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 132. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 133. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 134. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 135. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 136. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 137. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 138. South Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 139. South Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 140. South Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 141. South Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 142. South Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 143. South Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 144. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 145. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 146. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 147. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 148. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 149. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 150. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 151. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 152. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 153. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 154. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 155. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 156. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 157. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 158. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 159. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 160. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 161. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 162. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 163. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 164. Brazil: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 165. Brazil: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 166. Brazil: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 167. Brazil: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 168. Brazil: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 169. Brazil: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 170. Argentina: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 171. Argentina: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 172. Argentina: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 173. Argentina: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 174. Argentina: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 175. Argentina: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 176. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 177. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 178. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 179. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 180. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 181. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 182. Heat Map Analysis by Key Players
  • Table 183. Recent Organic Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
  • Table 184. Recent Inorganic Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
  • Table 185. Glossary of Terms, Infectious Disease Diagnostics Market

List Of Figures

  • Figure 1. DNA Plasmid Manufacturing Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. DNA Plasmid Manufacturing Market Revenue (US$ Million), 2021-2031
  • Figure 5. DNA Plasmid Manufacturing Market Share (%) - by Product Type (2024 and 2031)
  • Figure 6. GMP Grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. R&D grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. DNA Plasmid Manufacturing Market Share (%) - by Application (2024 and 2031)
  • Figure 9. Cell and Gene Therapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. DNA Vaccines: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Immunotherapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. DNA Plasmid Manufacturing Market Share (%) - by End User (2024 and 2031)
  • Figure 14. Pharmaceutical and Biotechnology Companies: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. CROs and CDMOs: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. DNA Plasmid Manufacturing Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 18. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 19. North America: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 20. North America: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 21. North America: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 22. North America: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 23. United States: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Canada: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 25. Mexico: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 27. Europe: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 28. Europe: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 29. Europe: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 30. Europe: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 31. Germany: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. United Kingdom: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. France: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Italy: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Spain: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 37. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 38. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 39. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 40. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 41. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 42. China: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 43. Japan: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 44. India: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 45. Australia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 46. South Korea: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 48. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 49. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 50. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 51. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 52. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 53. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 54. South Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 55. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 56. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 57. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 58. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 59. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 60. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 61. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 62. Brazil: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 63. Argentina: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 64. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 65. Company Market Share Analysis, 2024
  • Figure 66. Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market